Stock Trading History of Schimmel Paul

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Schimmel Paul since year 2005. The trader's CIK number is 1236447. At the time of this reporting, Schimmel Paul is the Director of Alnylam Pharmaceuticals, Inc. (stock ticker symbol ALNY).
Note that in the past SCHIMMEL PAUL also reported insider trading activities as an insider of the following companies:

Alnylam Pharmaceuticals, Inc. (ALNY)
Sirtris Pharmaceuticals, Inc. (SIRT)
Alkermes Inc (ALKS)
Repligen Corp (RGEN)

Stock purchases, sales, and option exercises reported by *Schimmel Paul* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-12-03	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	11,586	32.63	378,074
2007-11-30	ALNY	Alnylam Pharmaceuticals, Inc.	Option Exercise	20,000	10.91	218,200
2007-11-30	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	37,222	33.45	1,245,187
2007-12-04	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	7,192	31.89	229,352
2007-11-30	SIRT	Sirtris Pharmaceuticals, Inc.	Option Exercise	26,785	.42	11,249
2007-11-30	SIRT	Sirtris Pharmaceuticals, Inc.	Sale	11,503	17.00	195,608
2007-06-15	ALKS	Alkermes Inc	Option Exercise	5,000	7.94	39,700
2007-06-14	RGEN	Repligen Corp	Option Exercise	5,000	1.00	5,000
2006-08-11	RGEN	Repligen Corp	Option Exercise	5,000	.88	4,400
2006-08-11	RGEN	Repligen Corp	Option Exercise	5,000	.88	4,400
2006-03-02	ALKS	Alkermes Inc	Option Exercise	5,000	5.00	25,000
2006-03-02	ALKS	Alkermes Inc	Sale	5,000	26.00	130,000
2006-01-31	ALNY	Alnylam Pharmaceuticals, Inc.	Purchase	100,000	13.00	1,300,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schimmel Paul (Director of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.